EXAMINE THIS REPORT ON GEEK BAR LOGO 0 4

The introduction of nicotinamide for a nicotine alternative in e-cigarette and smokeless solutions represents a significant regulatory obstacle for your FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to act as a sedative at significant dosages6. The statements created by Nicotine River, ECBlend, together with ot